Acromegaly is a serious endocrine condition resulting from an excess of growth hormone (GH) in the blood. GH is released by the pituitary gland and is carried through the rest of the body where it has specific effects.
The presence of a pituitary tumor on magnetic resonance imaging confirmed the diagnostic hypothesis.
The FDA has approved the FlexPro PenMate is intended for users of Norditropin, which is indicated for patients with growth hormone-related disorders, who prefer hidden needles during injection.
Results show increased hospital charges, costs and length of stay for patients treated by lower-volume surgeons.
Copeptin represents a novel, early marker for postoperative diabetes insipidus after pituitary surgery.
The FDA has approved pasireotide (Signifor long-acting release) for treatment of acromegaly.
The Endocrine Society has issued a clinical practice guideline for the diagnosis and treatment of acromegaly.
Cardiovascular morbidity and mortality may be increased in people with higher values of fasting growth hormone.
Patients with growth hormone deficiency reaped significant benefits in quality of live over the long term.
Proton irradiation is an effective treatment for functional pituitary adenomas, and hypopituitarism remains the primary adverse effect.
In patients with acromegaly, ATL1103 significantly reduced serum insulin-like growth factor I (IGF-1) after 14 weeks of treatment.
Endocrinology Advisor Articles
- Effect of Sugar-Sweetened Beverages on Obesity Development
- Metformin and PCOS: Improving Menstrual Cycle and Hormone Profiles
- Denosumab May Increase BMD in Women With Primary Hyperparathyroidism
- T2D May Play a Protective Role Against Developing Aortic Diseases
- Risk Factors for Diabetes May Be Identified 20 Years Before Diagnosis
- Metformin Safe in T2D With Moderate to Severe Chronic Kidney Disease
- SGLT2 Inhibitors Show High Cardiovascular- and Renal-Protective Effects in T2D
- Type 2 Diabetes Insulin Initiation: Predictors Identified
- Two New Diabetes Medications Now Available
- Managing Acute Pain in Patients With Severe Obesity
- Risk for Congenital Malformations With Antithyroid Drugs
- Occupational Therapy May Benefit Young Adults With Diabetes
- Weight Loss May Improve Pain in Patients With Obesity
- Prior Authorizations Are Creating a Challenge for Clinicians
- Effect of Biologic DMARDs on Spinal Fracture Risk in Ankylosing Spondylitis